Skadden and Goldfarb Gross Seligman & Co. are advising the Special Committee, which was formed by Taro’s Board of Directors. Herzog, Fox & Neeman and Davis...
Taro’s Merger Agreement with Sun Pharma
Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...